000 01367 a2200361 4500
005 20250517163738.0
264 0 _c20180212
008 201802s 0 0 eng d
022 _a2051-1426
024 7 _a10.1186/s40425-017-0257-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCannarile, Michael A
245 0 0 _aColony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
_h[electronic resource]
260 _bJournal for immunotherapy of cancer
_c07 2017
300 _a53 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents, Immunological
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aNeoplasms
_xtherapy
650 0 4 _aPatient Safety
650 0 4 _aReceptors, Granulocyte-Macrophage Colony-Stimulating Factor
_xantagonists & inhibitors
700 1 _aWeisser, Martin
700 1 _aJacob, Wolfgang
700 1 _aJegg, Anna-Maria
700 1 _aRies, Carola H
700 1 _aRüttinger, Dominik
773 0 _tJournal for immunotherapy of cancer
_gvol. 5
_gno. 1
_gp. 53
856 4 0 _uhttps://doi.org/10.1186/s40425-017-0257-y
_zAvailable from publisher's website
999 _c27375876
_d27375876